These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24627601)

  • 1. Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats.
    Tanaka K; Masaki Y; Tanaka M; Miyazaki M; Enjoji M; Nakamuta M; Kato M; Nomura M; Inoguchi T; Kotoh K; Takayanagi R
    World J Gastroenterol; 2014 Mar; 20(10):2653-63. PubMed ID: 24627601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 is effective against metabolic disorders induced by intrauterine and postnatal overnutrition in rodents.
    Chen H; Simar D; Pegg K; Saad S; Palmer C; Morris MJ
    Diabetologia; 2014 Mar; 57(3):614-22. PubMed ID: 24337156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice.
    Cruz MM; Simão JJ; de Sá RDCC; Farias TSM; da Silva VS; Abdala F; Antraco VJ; Armelin-Correa L; Alonso-Vale MIC
    Front Endocrinol (Lausanne); 2020; 11():537061. PubMed ID: 33117273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in non-diabetic, morbidly obese patients.
    Camastra S; Astiarraga B; Tura A; Frascerra S; Ciociaro D; Mari A; Gastaldelli A; Ferrannini E
    Diabetes Obes Metab; 2017 Mar; 19(3):412-420. PubMed ID: 27898183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease.
    Li S; Wang X; Zhang J; Li J; Liu X; Ma Y; Han C; Zhang L; Zheng L
    Braz J Med Biol Res; 2018; 51(8):e7299. PubMed ID: 29924135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flavan-3-ol fraction of cocoa powder suppressed changes associated with early-stage metabolic syndrome in high-fat diet-fed rats.
    Osakabe N; Hoshi J; Kudo N; Shibata M
    Life Sci; 2014 Sep; 114(1):51-6. PubMed ID: 25132363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cecropia peltata ethanolic extract reduces insulin resistance and hepatic steatosis in rats fed a high-fat diet.
    Duarte-Alonso A; Cu-Cañetas TE; Avila-Nava A; Sansores-España D; Acevedo-Fernández JJ; Sandoval-Peraza M; Chel-Guerrero L; Torre-Villalvazo I
    J Ethnopharmacol; 2020 Oct; 261():113087. PubMed ID: 32534116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Xylose suppresses adipogenesis and regulates lipid metabolism genes in high-fat diet-induced obese mice.
    Lim E; Lim JY; Shin JH; Seok PR; Jung S; Yoo SH; Kim Y
    Nutr Res; 2015 Jul; 35(7):626-36. PubMed ID: 26088373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice.
    Obata A; Kubota N; Kubota T; Iwamoto M; Sato H; Sakurai Y; Takamoto I; Katsuyama H; Suzuki Y; Fukazawa M; Ikeda S; Iwayama K; Tokuyama K; Ueki K; Kadowaki T
    Endocrinology; 2016 Mar; 157(3):1029-42. PubMed ID: 26713783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice.
    Lu H; Yuan X; Zhang Y; Han M; Liu S; Han K; Liang P; Cheng J
    Biomed Pharmacother; 2020 Sep; 129():110347. PubMed ID: 32535386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease.
    Jorgačević B; Vučević D; Vesković M; Mladenović D; Vukićević D; Vukićević RJ; Todorović V; Radosavljević T
    Can J Physiol Pharmacol; 2019 Feb; 97(2):120-129. PubMed ID: 30673308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platycodon grandiflorus Root Extract Attenuates Body Fat Mass, Hepatic Steatosis and Insulin Resistance through the Interplay between the Liver and Adipose Tissue.
    Kim YJ; Choi JY; Ryu R; Lee J; Cho SJ; Kwon EY; Lee MK; Liu KH; Rina Y; Sung MK; Choi MS
    Nutrients; 2016 Aug; 8(9):. PubMed ID: 27589792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
    Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.
    Zheng X; Xu F; Liang H; Cao H; Cai M; Xu W; Weng J
    Hepatology; 2017 Sep; 66(3):809-824. PubMed ID: 28439947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice.
    Lee KC; Hsieh YC; Yang YY; Chan CC; Huang YH; Lin HC
    Sci Rep; 2016 Jan; 6():18899. PubMed ID: 26732252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.
    Helal MG; Ayoub SE; Elkashefand WF; Ibrahim TM
    Hum Exp Toxicol; 2018 Sep; 37(9):983-990. PubMed ID: 29249184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
    Kalavalapalli S; Bril F; Guingab J; Vergara A; Garrett TJ; Sunny NE; Cusi K
    J Endocrinol; 2019 Jun; 241(3):293-305. PubMed ID: 31082799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.